Cosmetic differences between branded drugs, generics may reduce adherence

01/2/2013 | Medscape (free registration)

Differences in color and shape between branded drugs and their generic counterparts may be connected with prescription nonadherence, according to a controlled study published in the Archives of Internal Medicine. "Changes between generic products with different physical characteristics may cause confusion and result in reduced adherence or prescription error," researchers wrote. "Taking steps to permit (or even require) similarity in pill appearance among bioequivalent brand-name and generic drugs may offer another way to achieve better patient adherence to essential medication regimens."

View Full Article in:

Medscape (free registration)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Director, Research
America's Health Insurance Plans (AHIP)
Washington, DC
Stop Loss Sales Executive
Blue Cross Blue Shield of MA
Boston, MA
Regional Director, Southeastern Region - State Affairs
America's Health Insurance Plans (AHIP)
Washington, DC
Field Representative-Oklahoma and Kansas
National Rural Electric Cooperative Association (NRECA)
Multiple Locations, SL_Multiple Locations
Market Intelligence Manager
Olympus Corporation of the Americas
Southborough, MA